DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task
Executive Summary
FDA's Office of the Chief Counsel has assigned two additional lawyers to review draft regulatory letters from the Division of Drug Marketing, Advertising & Communications